Treatment of Obesity: Should We Target the Individual or Society?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|15|1151-1163

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.15, 2003-06, pp. : 1151-1163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GPR 120: The Potential Target for Obesity Treatment

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 1, 2016-03 ,pp. : 8-11

Bentham Science Publishers

Access to resources Recommend Favorite

Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?

By  

Current Drug Targets, Vol. 11, Iss. 1, 2010-01 ,pp. : 122-135

Bentham Science Publishers

Access to resources Recommend Favorite

Should we use probiotics as supportive treatment for hereditary angioedema?

By Madalinski K.   Jaworska H.   Gregorek H.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 26-26

Elsevier

Access to resources Recommend Favorite

CCK1R Agonists: A Promising Target for the Pharmacological Treatment of Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 8, 2003-05 ,pp. : 837-854

Bentham Science Publishers

Access to resources Recommend Favorite

Should we Target Allergen Protease Activity to Decrease the Burden of Allergic Airway Inflammation?

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 4, 2008-12 ,pp. : 288-295

Bentham Science Publishers

Access to resources Recommend Favorite